Tang Wen-Juan, Hu Wen-Hui, Huang Ying, Wu Bing-Bing, Peng Xiao-Min, Zhai Xiao-Wen, Qian Xiao-Wen, Ye Zi-Qing, Xia Hai-Jiao, Wu Jie, Shi Jie-Ru
Department of Gastroenterology, Pediatric Inflammatory Bowel Disease Research Center, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.
The Molecular Genetic Diagnosis Center, Children's Hospital of Fudan University, Shanghai 201102, China.
World J Clin Cases. 2021 Jul 26;9(21):5873-5888. doi: 10.12998/wjcc.v9.i21.5873.
Patients with lipopolysaccharide (LPS)-responsive beige-like anchor protein (LRBA) deficiency have a variety of clinical symptoms, but there is no apparent genotype-phenotype correlation, and patients carrying the same mutations may have different phenotypes. Therefore, it is not easy for doctors to make a decision regarding hematopoietic stem cell transplantation (HSCT) for LRBA-deficient patients. We hypothesized that there may be a protein-phenotype correlation to indicate HSCT for LRBA-deficient patients.
To report on three Chinese LRBA-deficient patients and determine the correlation between residual protein expression and disease phenotypes
Clinical data of three Chinese LRBA-deficient patients were collected, and protein levels were detected by Western blot analysis. In addition, LRBA mutation information of another 83 previously reported patients was summarized.
All the major clinical findings indicated enteropathy, but patients 1 and 3 presented with more severe symptoms than patient 2. Endoscopy and histology indicated nonspecific colitis for patients 1 and 3 but Crohn's disease-like colitis for patient 2. Compound heterozygous mutations in LRBA were found in patient 1, and homozygous mutations in LRBA were found in patient 2 and patient 3. Only patient 2 responded well to traditional immunosuppressive treatment. Residual expression of the LRBA protein in patients 1 and 3 was very low, but in patient 2, a more than 0.5-fold in expression of the LRBA protein was found compared to that in the control. After HSCT, patient 1 had increased LRBA protein expression. We summarized the genetic information of 86 patients, and the mutations in patients 1 and 3 were novel mutations.
We described three Chinese LRBA-deficient patients, two of whom carried novel mutations. These patients had no genotype-phenotype correlations, but their residual LRBA protein expression might be associated with disease outcome and could be an indicator for HSCT.
脂多糖(LPS)反应性米色样锚定蛋白(LRBA)缺乏症患者有多种临床症状,但不存在明显的基因型-表型相关性,且携带相同突变的患者可能有不同表型。因此,医生很难就LRBA缺乏症患者的造血干细胞移植(HSCT)做出决策。我们推测可能存在蛋白质-表型相关性以指导LRBA缺乏症患者的HSCT。
报告3例中国LRBA缺乏症患者,并确定残余蛋白表达与疾病表型之间的相关性。
收集3例中国LRBA缺乏症患者的临床资料,通过蛋白质免疫印迹分析检测蛋白水平。此外,总结了另外83例先前报道患者的LRBA突变信息。
所有主要临床发现均提示存在肠病,但患者1和患者3的症状比患者2更严重。内镜检查和组织学检查显示患者1和患者3为非特异性结肠炎,而患者2为克罗恩病样结肠炎。患者1发现LRBA复合杂合突变,患者2和患者3发现LRBA纯合突变。仅患者2对传统免疫抑制治疗反应良好。患者1和患者3的LRBA蛋白残余表达非常低,但患者2的LRBA蛋白表达比对照高0.5倍以上。HSCT后,患者1的LRBA蛋白表达增加。我们总结了86例患者的遗传信息,患者1和患者3的突变是新突变。
我们描述了3例中国LRBA缺乏症患者,其中2例携带新突变。这些患者不存在基因型-表型相关性,但其LRBA蛋白残余表达可能与疾病转归相关,并且可能是HSCT的一个指标。